Recent advances in immunoassay technologies for the detection of human coronavirus infections

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the seventh coronavirus (CoV) that has spread in humans and has become a global pandemic since late 2019. Efficient and accurate laboratory diagnostic methods are one of the crucial means to control the development of the current pandem...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cellular and infection microbiology Vol. 12; p. 1040248
Main Authors: Wang, Danqi, Chen, Yuejun, Xiang, Shan, Hu, Huiting, Zhan, Yujuan, Yu, Ying, Zhang, Jingwen, Wu, Pian, Liu, Fei Yue, Kai, Tianhan, Ding, Ping
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 04-01-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the seventh coronavirus (CoV) that has spread in humans and has become a global pandemic since late 2019. Efficient and accurate laboratory diagnostic methods are one of the crucial means to control the development of the current pandemic and to prevent potential future outbreaks. Although real-time reverse transcription-polymerase chain reaction (rRT-PCR) is the preferred laboratory method recommended by the World Health Organization (WHO) for diagnosing and screening SARS-CoV-2 infection, the versatile immunoassays still play an important role for pandemic control. They can be used not only as supplemental tools to identify cases missed by rRT-PCR, but also for first-line screening tests in areas with limited medical resources. Moreover, they are also indispensable tools for retrospective epidemiological surveys and the evaluation of the effectiveness of vaccination. In this review, we summarize the mainstream immunoassay methods for human coronaviruses (HCoVs) and address their benefits, limitations, and applications. Then, technical strategies based on bioinformatics and advanced biosensors were proposed to improve the performance of these methods. Finally, future suggestions and possibilities that can lead to higher sensitivity and specificity are provided for further research.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Edited by: Parveen Kumar, University of Alabama at Birmingham, United States
This article was submitted to Clinical Microbiology, a section of the journal Frontiers in Cellular and Infection Microbiology
Reviewed by: Wentao Li, Huazhong Agricultural University, China; Ritesh Sevalkar, University of Alabama at Birmingham, United States
These authors have contributed equally to this work
ISSN:2235-2988
2235-2988
DOI:10.3389/fcimb.2022.1040248